Chlorhexidine and silver sulfadiazine coating on central venous catheters is not sufficient for protection against catheter-related infection: Simulation-based laboratory research with clinical validation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Yoon Ji | - |
dc.contributor.author | Lim, Jae Kwan | - |
dc.contributor.author | Park, Jeong Jun | - |
dc.contributor.author | Huh, Hyub | - |
dc.contributor.author | Kim, Dong-Joo | - |
dc.contributor.author | Gong, Chang-Hoon | - |
dc.contributor.author | Yoon, Seung Zhoo | - |
dc.date.accessioned | 2021-09-03T05:25:11Z | - |
dc.date.available | 2021-09-03T05:25:11Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2017-06 | - |
dc.identifier.issn | 0300-0605 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/83224 | - |
dc.description.abstract | Objective The efficacy of chlorhexidine- and silver sulfadiazine-coated central venous catheters (CSS-CVC) against catheter-related infection remains controversial. We hypothesized that the loss of silver nanoparticles may reduce the antibacterial efficacy of CSS-CVCs and that this loss could be due to the frictional force between the surface of the CVC and the bloodstream. The objective of this study was to investigate whether the antimicrobial effect of CSS-CVCs decreases with increasing exposure time in a bloodstream model and quantitatively assay the antimicrobial effect of CSS-CVCs compared with polyurethane and antiseptic-impregnated CVCs. Methods Each CVC was subjected to 120 hours of saline flow and analyzed at intervals over 24 hours. The analyses included energy-dispersive X-ray spectroscopy, scanning electron microscopy, and optical density after a Staphylococcus aureus incubation test. Results The weight percentage of silver in the CSS-CVCs significantly decreased to 56.18% (44.10%3.32%) with 48-hour catheterization and to 18.88% (14.82%+/- 1.33%) with 120-hour catheterization compared with the initial weight percentage (78.50%+/- 6.32%). In the S. aureus incubation test, the antibacterial function of CSS-CVCs was lost after 48 hours [3 (N/D) of OD]. Similar results were observed in a pilot clinical study using 18 CSS-CVCs. Conclusions We found that the efficacy of CSS-CVCs decreased over time and that the antibacterial function was lost after 48 hours of simulated wear-out. Therefore, antibiotic-impregnated CVCs may be a better option when longer (>48 hours) indwelling is needed. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | SAGE PUBLICATIONS LTD | - |
dc.subject | BLOOD-STREAM INFECTION | - |
dc.subject | ANTIMICROBIAL ACTIVITY | - |
dc.subject | BACTERIAL-COLONIZATION | - |
dc.subject | MEDICAL DEVICES | - |
dc.subject | NANOPARTICLES | - |
dc.subject | PREVENTION | - |
dc.subject | EXERCISE | - |
dc.subject | EFFICACY | - |
dc.subject | ACCESS | - |
dc.title | Chlorhexidine and silver sulfadiazine coating on central venous catheters is not sufficient for protection against catheter-related infection: Simulation-based laboratory research with clinical validation | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Yoon Ji | - |
dc.contributor.affiliatedAuthor | Huh, Hyub | - |
dc.contributor.affiliatedAuthor | Kim, Dong-Joo | - |
dc.contributor.affiliatedAuthor | Yoon, Seung Zhoo | - |
dc.identifier.doi | 10.1177/0300060517708944 | - |
dc.identifier.scopusid | 2-s2.0-85021291117 | - |
dc.identifier.wosid | 000404171400015 | - |
dc.identifier.bibliographicCitation | JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, v.45, no.3, pp.1042 - 1053 | - |
dc.relation.isPartOf | JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | - |
dc.citation.title | JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | - |
dc.citation.volume | 45 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 1042 | - |
dc.citation.endPage | 1053 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | BLOOD-STREAM INFECTION | - |
dc.subject.keywordPlus | ANTIMICROBIAL ACTIVITY | - |
dc.subject.keywordPlus | BACTERIAL-COLONIZATION | - |
dc.subject.keywordPlus | MEDICAL DEVICES | - |
dc.subject.keywordPlus | NANOPARTICLES | - |
dc.subject.keywordPlus | PREVENTION | - |
dc.subject.keywordPlus | EXERCISE | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | ACCESS | - |
dc.subject.keywordAuthor | Antibacterial activity | - |
dc.subject.keywordAuthor | bloodstream model | - |
dc.subject.keywordAuthor | central line infections | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.